Tocqueville Asset Management L.P. decreased its holdings in Thermo Fisher Scientific Inc (NYSE:TMO) by 4.5% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 209,605 shares of the medical research company’s stock after selling 9,839 shares during the period. Tocqueville Asset Management L.P. owned about 0.05% of Thermo Fisher Scientific worth $39,657,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also added to or reduced their stakes in the company. BlackRock Inc. increased its stake in shares of Thermo Fisher Scientific by 2,692.1% during the first quarter. BlackRock Inc. now owns 22,988,885 shares of the medical research company’s stock valued at $3,531,095,000 after buying an additional 22,165,530 shares during the period. Capital Research Global Investors increased its stake in shares of Thermo Fisher Scientific by 29.8% during the second quarter. Capital Research Global Investors now owns 17,304,897 shares of the medical research company’s stock valued at $3,019,185,000 after buying an additional 3,973,136 shares during the period. Janus Henderson Group PLC increased its stake in shares of Thermo Fisher Scientific by 2,058.1% during the second quarter. Janus Henderson Group PLC now owns 2,342,046 shares of the medical research company’s stock valued at $408,620,000 after buying an additional 2,233,522 shares during the period. Veritas Asset Management LLP increased its stake in shares of Thermo Fisher Scientific by 112.4% during the second quarter. Veritas Asset Management LLP now owns 2,430,759 shares of the medical research company’s stock valued at $424,095,000 after buying an additional 1,286,259 shares during the period. Finally, Harbour Capital Advisors LLC increased its stake in shares of Thermo Fisher Scientific by 18,197.5% during the second quarter. Harbour Capital Advisors LLC now owns 1,201,051 shares of the medical research company’s stock valued at $6,884,000 after buying an additional 1,194,487 shares during the period. Institutional investors and hedge funds own 85.32% of the company’s stock.

In other Thermo Fisher Scientific news, Director C Martin Harris sold 360 shares of the firm’s stock in a transaction dated Wednesday, August 30th. The stock was sold at an average price of $180.97, for a total value of $65,149.20. Following the completion of the sale, the director now owns 5,312 shares of the company’s stock, valued at $961,312.64. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CEO Marc N. Casper sold 50,000 shares of the firm’s stock in a transaction dated Wednesday, November 15th. The stock was sold at an average price of $188.39, for a total value of $9,419,500.00. Following the completion of the sale, the chief executive officer now directly owns 252,577 shares of the company’s stock, valued at approximately $47,582,981.03. The disclosure for this sale can be found here. In the last three months, insiders sold 60,420 shares of company stock valued at $11,308,477. Corporate insiders own 0.49% of the company’s stock.

Several brokerages have recently commented on TMO. Jefferies Group LLC restated a “hold” rating and set a $195.00 price target on shares of Thermo Fisher Scientific in a research note on Thursday, September 28th. Zacks Investment Research upgraded Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $208.00 price target on the stock in a research note on Thursday, September 7th. Argus restated a “buy” rating on shares of Thermo Fisher Scientific in a research note on Tuesday, August 22nd. They noted that the move was a valuation call. Morgan Stanley reiterated an “overweight” rating and issued a $220.00 target price on shares of Thermo Fisher Scientific in a research note on Wednesday, September 6th. Finally, Goldman Sachs Group, Inc. (The) started coverage on Thermo Fisher Scientific in a research note on Tuesday, September 26th. They issued a “buy” rating and a $225.00 target price on the stock. One equities research analyst has rated the stock with a hold rating and sixteen have issued a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and a consensus target price of $205.71.

WARNING: “Thermo Fisher Scientific Inc (TMO) Holdings Trimmed by Tocqueville Asset Management L.P.” was first posted by Watch List News and is the property of of Watch List News. If you are accessing this news story on another site, it was stolen and republished in violation of United States and international copyright and trademark legislation. The legal version of this news story can be read at https://www.watchlistnews.com/thermo-fisher-scientific-inc-tmo-holdings-trimmed-by-tocqueville-asset-management-l-p/1721301.html.

Shares of Thermo Fisher Scientific Inc (NYSE TMO) opened at $192.75 on Thursday. The company has a quick ratio of 0.81, a current ratio of 1.26 and a debt-to-equity ratio of 0.85. The firm has a market capitalization of $77,364.04, a PE ratio of 21.20, a price-to-earnings-growth ratio of 1.77 and a beta of 1.08. Thermo Fisher Scientific Inc has a twelve month low of $139.07 and a twelve month high of $201.20.

Thermo Fisher Scientific (NYSE:TMO) last issued its quarterly earnings results on Wednesday, October 25th. The medical research company reported $2.31 earnings per share for the quarter, topping the consensus estimate of $2.24 by $0.07. The business had revenue of $5.12 billion during the quarter, compared to the consensus estimate of $5.03 billion. Thermo Fisher Scientific had a return on equity of 15.94% and a net margin of 11.73%. The company’s quarterly revenue was up 13.9% on a year-over-year basis. During the same quarter last year, the company earned $2.03 earnings per share. sell-side analysts forecast that Thermo Fisher Scientific Inc will post 9.36 EPS for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Monday, January 15th. Shareholders of record on Friday, December 15th will be issued a $0.15 dividend. This represents a $0.60 annualized dividend and a yield of 0.31%. The ex-dividend date is Thursday, December 14th. Thermo Fisher Scientific’s dividend payout ratio is presently 10.19%.

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.